Ubs Asset Management Americas Inc Albireo Pharma, Inc. Transaction History

Ubs Asset Management Americas Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $136,027 - $273,596	-7,337 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.9 - $36.87 $32,859 - $41,921	1,137 Added 18.34%	7,337 $258,000
Q1 2021 May 14, 2021	SELL	$32.03 - $42.85 $16,015 - $21,425	-500 Reduced 7.46%	6,200 $218,000
Q4 2020 Mar 01, 2021	BUY	$31.56 - $42.16 $211,452 - $282,472	6,700 New	6,700 $251,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.